Skip to main content
Skip to footer
Menu
Who We Are
Our Focus : Mitral Regurgitation
Our TSMVR Solution
News
Contact
fr
News
Follow Our Latest Developments and Achievements
Press releases
Events
Media
EuroPCR – Paris (France), May 20-23
HighLife granted US FDA Breakthrough Device Designation for its TMVR solution
London Valves – UK, November 24-26
TCT – Washington (USA), October 27-30
AVAM – Bordeaux (France), October 2-4
HighLife Receives ISO 13485 Certification of its Quality Management System
HighLife welcomes Stefan Pilz as new Chief Executive Officer
HighLife Receives IDE Approval to Initiate US Pivotal Clinical Study for treatment of Mitral Regurgitation
1
2
3
4
Top
